Kailera Therapeutics, Inc.

NasdaqGS:KLRA Stock Report

Market Cap: US$2.4b

Kailera Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:KLRA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Apr 26BuyUS$25,000,000Bain Capital Life Sciences Investors, LLCCompany1,562,500US$16.00
20 Apr 26BuyUS$134,375,008Bain Capital, LPCompany8,398,438US$16.00
20 Apr 26BuyUS$8,000,000RTW Investments, LPCompany500,000US$16.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KLRA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders38,0940.0294%
Hedge Funds10,776,8208.32%
Public Companies11,511,8538.88%
Institutions23,079,90117.8%
General Public35,320,09127.3%
VC/PE Firms48,838,84937.7%

Dilution of Shares: KLRA only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 72.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.3%
Bain Capital, LP
26,255,581US$477.1m0%4.98%
17.4%
Bain Capital Life Sciences Investors, LLC
22,583,268US$410.3m0%30.61%
8.88%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
11,511,853US$209.2m1,150,000,000%no data
8.32%
RTW Investments, LP
10,776,820US$195.8m0%1.65%
3.86%
Canada Pension Plan Investment Board
5,000,000US$90.9m0%0.04%
2.29%
FMR LLC
2,969,832US$54.0m0%no data
1.98%
BlackRock, Inc.
2,564,258US$46.6m0%no data
1.66%
Wellington Management Group LLP
2,146,616US$39.0m0%0.01%
1.52%
T. Rowe Price Group, Inc.
1,975,851US$35.9m0%no data
1.44%
Atlas Venture Advisors, Inc.
1,868,513US$34.0m0%4.16%
1.31%
Vanguard Capital Management, LLC
1,693,958US$30.8m0%no data
1.28%
Vanguard Portfolio Management, LLC
1,652,507US$30.0m0%no data
0.54%
Columbia Management Investment Advisers, LLC
701,996US$12.8m0%no data
0.39%
Federated Hermes, Inc.
500,000US$9.1m0%0.01%
0.31%
Franklin Resources, Inc.
400,000US$7.3m0%no data
0.22%
Vanguard Fiduciary Trust Company
290,128US$5.3m0%no data
0.17%
Charles Schwab Investment Management, Inc.
223,708US$4.1m0%no data
0.12%
Exchange Traded Concepts, LLC
152,501US$2.8m0%0.01%
0.11%
TD Asset Management, Inc.
147,698US$2.7m0%no data
0.11%
Aberdeen Group Plc
140,000US$2.5m0%no data
0.1%
Hartford Funds Management Company, LLC
133,356US$2.4m0%0.01%
0.1%
ALPS Advisors, Inc.
131,000US$2.4m0%0.01%
0.072%
State Street Investment Management
92,748US$1.7m0%no data
0.064%
Strategic Advisers LLC
82,700US$1.5m0%no data
0.029%
Ronald Renaud
38,094US$692.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/06 05:20
End of Day Share Price 2026/08/05 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kailera Therapeutics, Inc. is covered by 6 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Umer RaffatEvercore ISI
Roger SongJefferies LLC
Hardik ParikhJ.P. Morgan